دورية أكاديمية

93P The survival impact of the addition of durvalumab to cisplatin/gemcitabine in advanced biliary tract cancer: A real-world, retrospective, multicentric study

التفاصيل البيبلوغرافية
العنوان: 93P The survival impact of the addition of durvalumab to cisplatin/gemcitabine in advanced biliary tract cancer: A real-world, retrospective, multicentric study
المؤلفون: Rimini, M., Persano, M., Fornaro, L., Antonuzzo, L., Lonardi, S., Rimassa, L., Niger, M., Silletta, M., Tamburini, E., Giordano, G., Scartozzi, M., Pastorino, A., Martinelli, E., Rizzato, M.D., Gardini, A. Casadei
المصدر: In Immuno-Oncology and Technology December 2023 20 Supplement
قاعدة البيانات: ScienceDirect
الوصف
تدمد:25900188
DOI:10.1016/j.iotech.2023.100565